Genetic Analysis Investor Relations Material
Latest events
Status Update
Genetic Analysis
Q1 2025
27 May, 2025
Q4 2024
26 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Genetic Analysis
Access all reports
Genetic Analysis develops and markets diagnostic tests based on microbiome profiling technologies. Its solutions are used in healthcare and research to analyze gut microbiota for disease risk and treatment optimization. The company is headquartered in Oslo, Norway, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
GEAN
Country
🇳🇴 Norway